But selecting the location for the company’s U.S. presence was only the beginning. The next challenge was the
task of hiring employees. Because MorphoSys believes its most precious resource are its people, their values and
their networks of influence, talent acquisition was a top priority. MorphoSys successfully added nearly 40
full-time U.S. team members in 2019, and plans to continue hiring, aiming to increase the number to over 150
employees by mid-2020.
The MorphoSys U.S. team is comprised of professionals from many different disciplines and is prepared to reach
out to all critical stakeholders including patients, healthcare providers, payers, policy makers and patient
Representing the talented group of professionals that have become a part of the MorphoSys family in the U.S.,
David Trexler, President of MorphoSys US Inc., and Dr. Nuwan Kurukulasuriya, Senior Vice
President and Head of Medical Affairs, both seasoned industry experts, commented on the progress and the
importance of transatlantic collaboration on the way to bringing tafasitamab to patients in need.